Shares of BridgeBio Pharma, Inc. (BBIO) surged 5.02% during intraday trading on Wednesday, reflecting a significant uptick in investor sentiment.
The move follows a report indicating that analysts are expressing bullish views on the healthcare stock. Positive analyst commentary often serves as a catalyst for increased investor confidence and buying activity in a company's shares.